Cargando…
Integration of Tobacco Treatment Services into Cancer Care at Stanford
As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was e...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143650/ https://www.ncbi.nlm.nih.gov/pubmed/32235713 http://dx.doi.org/10.3390/ijerph17062101 |
_version_ | 1783519662554742784 |
---|---|
author | Gali, Kathleen Pike, Brittany Kendra, Matthew S. Tran, Cindy Fielding-Singh, Priya Jimenez, Kayla Mirkin, Rachelle Prochaska, Judith J. |
author_facet | Gali, Kathleen Pike, Brittany Kendra, Matthew S. Tran, Cindy Fielding-Singh, Priya Jimenez, Kayla Mirkin, Rachelle Prochaska, Judith J. |
author_sort | Gali, Kathleen |
collection | PubMed |
description | As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was engaged first in January 2019 as a pilot site given staff receptivity, elevated smoking prevalence, and a high tobacco screening rate (95%) yet low levels of tobacco cessation treatment referrals (<10%) and patient engagement (<1% of smokers treated). To improve referrals and engagement, system changes included an automated “opt-out” referral process and provision of tobacco cessation treatment as a covered benefit with flexible delivery options that included phone and telemedicine. Screening rates increased to 99%, referrals to 100%, 74% of patients were reached by counselors, and 33% of those reached engaged in treatment. Patient-reported abstinence from all tobacco products at 6-month follow-up is 20%. In July 2019, two additional oncology clinics were added. In December 2019, less than one year from initiating the QI pilot, with demonstrated feasibility, acceptability, and efficacy, the tobacco treatment services were integrated into 14 clinics at Stanford Cancer Center. |
format | Online Article Text |
id | pubmed-7143650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71436502020-04-14 Integration of Tobacco Treatment Services into Cancer Care at Stanford Gali, Kathleen Pike, Brittany Kendra, Matthew S. Tran, Cindy Fielding-Singh, Priya Jimenez, Kayla Mirkin, Rachelle Prochaska, Judith J. Int J Environ Res Public Health Article As part of a National Cancer Institute Moonshot P30 Supplement, the Stanford Cancer Center piloted and integrated tobacco treatment into cancer care. This quality improvement (QI) project reports on the process from initial pilot to adoption within 14 clinics. The Head and Neck Oncology Clinic was engaged first in January 2019 as a pilot site given staff receptivity, elevated smoking prevalence, and a high tobacco screening rate (95%) yet low levels of tobacco cessation treatment referrals (<10%) and patient engagement (<1% of smokers treated). To improve referrals and engagement, system changes included an automated “opt-out” referral process and provision of tobacco cessation treatment as a covered benefit with flexible delivery options that included phone and telemedicine. Screening rates increased to 99%, referrals to 100%, 74% of patients were reached by counselors, and 33% of those reached engaged in treatment. Patient-reported abstinence from all tobacco products at 6-month follow-up is 20%. In July 2019, two additional oncology clinics were added. In December 2019, less than one year from initiating the QI pilot, with demonstrated feasibility, acceptability, and efficacy, the tobacco treatment services were integrated into 14 clinics at Stanford Cancer Center. MDPI 2020-03-22 2020-03 /pmc/articles/PMC7143650/ /pubmed/32235713 http://dx.doi.org/10.3390/ijerph17062101 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gali, Kathleen Pike, Brittany Kendra, Matthew S. Tran, Cindy Fielding-Singh, Priya Jimenez, Kayla Mirkin, Rachelle Prochaska, Judith J. Integration of Tobacco Treatment Services into Cancer Care at Stanford |
title | Integration of Tobacco Treatment Services into Cancer Care at Stanford |
title_full | Integration of Tobacco Treatment Services into Cancer Care at Stanford |
title_fullStr | Integration of Tobacco Treatment Services into Cancer Care at Stanford |
title_full_unstemmed | Integration of Tobacco Treatment Services into Cancer Care at Stanford |
title_short | Integration of Tobacco Treatment Services into Cancer Care at Stanford |
title_sort | integration of tobacco treatment services into cancer care at stanford |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143650/ https://www.ncbi.nlm.nih.gov/pubmed/32235713 http://dx.doi.org/10.3390/ijerph17062101 |
work_keys_str_mv | AT galikathleen integrationoftobaccotreatmentservicesintocancercareatstanford AT pikebrittany integrationoftobaccotreatmentservicesintocancercareatstanford AT kendramatthews integrationoftobaccotreatmentservicesintocancercareatstanford AT trancindy integrationoftobaccotreatmentservicesintocancercareatstanford AT fieldingsinghpriya integrationoftobaccotreatmentservicesintocancercareatstanford AT jimenezkayla integrationoftobaccotreatmentservicesintocancercareatstanford AT mirkinrachelle integrationoftobaccotreatmentservicesintocancercareatstanford AT prochaskajudithj integrationoftobaccotreatmentservicesintocancercareatstanford |